ClinicalTrials.gov
public full text
Public Domain
The Long Term Effect of Inhaled Hypertonic Saline (6%) in Patients With Non Cystic Fibrosis Bronchiectasis
The purpose of this study is to determine whether the daily inhalation of nebulised hypertonic saline (6%) will decrease the incidence of pulmonary exacerbations and increase the quality of life for people with non cystic fibrosis bronchiectasis.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Hypertonic Saline (6%) Versus Isotonic Saline (0.9%) in Bronchiectasis#831844
- Nebulized 5% Hypertonic Saline for the Treatment of Bronchiolitis#869747
- Efficacy of Nebulized Hypertonic Saline in the Treatment of Acute Bronchiolitis#833580
- Nebulized 3% Hypertonic Saline in the Treatment of Acute Bronchiolitis#917652
- Nebulized 3% Hypertonic Saline vs. Standard of Care in Patients With Bronchiolitis#826019
Record · ID 1095695
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive